Gwen A. Melincoff, Director at SOLENO THERAPEUTICS INC (SLNO), bought 10,000 shares at $1.54 ($15K) on 2019-11-19, disclosed to the SEC on 2019-11-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.